
Olga Ziouzina MD
Participates in 3 items
Dr. Olga Ziouzina is a Clinical Assistant Professor at the University of Calgary, Alberta. She received her Diploma with Honours from Irkutsk Medical University, Irkutsk, Russia and an MD from the University of Manitoba in Winnipeg. She completed residency in Internal Medicine and Rheumatology at the University of Calgary and clinical research fellowship in Psoriatic Arthritis and Lupus at the Toronto Western Hospital, Ontario.
Her professional interests include clinical work and research in spondyloarthritis, psoriatic arthritis and uveitis. Together with Drs. Kherani, Williams and Fielden, she runs a combined multidisciplinary Uveitis Clinic in Calgary. She plays a main role in the creation of the Uveitis Clinic Database.
Dr. Ziouzina has authored and co-authored several published research articles in the area of psoriatic arthritis and uveitis. She has presented at Canadian and international conferences in ophthalmology and rheumatology, including the Western Canada Retina Meeting.
Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:
1. Abbvie
2. Amgen
3. Celegene
4. Janssen
5. Lilly
6. Novartis
7. Pfizer
Her professional interests include clinical work and research in spondyloarthritis, psoriatic arthritis and uveitis. Together with Drs. Kherani, Williams and Fielden, she runs a combined multidisciplinary Uveitis Clinic in Calgary. She plays a main role in the creation of the Uveitis Clinic Database.
Dr. Ziouzina has authored and co-authored several published research articles in the area of psoriatic arthritis and uveitis. She has presented at Canadian and international conferences in ophthalmology and rheumatology, including the Western Canada Retina Meeting.
Financial disclosure: I have/had an affiliation (financial or otherwise) with a commercial organization:
1. Abbvie
2. Amgen
3. Celegene
4. Janssen
5. Lilly
6. Novartis
7. Pfizer
Sessions in which Olga Ziouzina MD participates
sexta-feira 1 junho, 2018
Time Zone: (GMT-05:00) Eastern Time (US & Canada)
6:30
6:30 -
8:00 |
1 hour 30 minutes
LEARNING OBJECTIVES:At the end of this symposium, participants will be able to:Describe the advantages and limitations of various treatment strategies for uveitis, including local and systemic therapies, and choose the most appropriate line of therapy for different uveitis presentationsIndicate the advantages and limitations of anti-VEGF agents in treating intraocular neovascularisation or macular edema secondary to uveitis vs. other vasculopathic causes of...
7:35
7:35 -
7:52 |
17 minutes
7:50